A examination of how the United States pharmaceutical groups may be at risk of a alternate conflict with China and a survey that found health care professionals see nonhospital fitness services as a hazard was the most-study tale last week in the SmartBrief for Health Care Leaders. The other top stories: How a Colorado county is negotiating health care prices, fitness employers’ reliance on immigrants, and the future of 23andMe.
How alternate conflict with China could hit US pharmaceutical makers
The changing war with China may want to hit the pharmaceutical enterprise due to US reliance on China for prescribed drugs. Retired Brig. Gen. John Adams stated China ought to weaponize its dominance in pharmaceuticals. Rosemary Gibson, the creator of “ChinaRx — Exposing the Risks of America’s Dependence on China for Medicine,” stated China aims to disrupt and displace pharmaceutical products within the US.
Full Story: International Business Times
Survey: Most health execs view nonhospital health offerings as a danger
The 2019 State of Consumerism in Healthcare report with the aid of Kaufman Hall located that 88% of hospital and fitness machine leaders experience threatened by nonhospital competition. The executive’s named Amazon, CVS Health/Aetna, and Optum as massive threats.
Full Story: Becker’s Health IT & CIO Report
Colo. County negotiates lower prices with fitness care vendors
With fitness care fees and insurance premiums growing in Summit County, Colo., citizens and county leaders banded with groups to create the Peak Health Alliance to barter immediately with a neighborhood health center and medical practices. As a result, costs for care and coverage charges are predicted to be up to 20% decrease.
Full tale: The Colorado Sun (Denver)
Staffing shortage in US fitness care mitigated with the aid of immigrants
The health care industry is experiencing a national staffing scarcity alleviated only through the inflow of immigrant physicians and nurses. Health Affairs observed that immigrants made up 18.2% of the fitness care industry’s personnel in 2017.
Full Story: Bloomberg (tiered subscription model)
Wojcicki units destiny direction for 23andMe
23andMe co-founder and CEO Anne Wojcicki are preparing to present start to her 0.33 baby and manual the corporation’s future as a drug discovery companion and a personal fitness aid. The genetic trying out company has a drug-discovery cope with GSK, and Wojcicki is exploring avenues for supplying customers fitness coaching services primarily based on genetic profile.